Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ASPIRIN Cause Coronary artery occlusion? 190 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 190 reports of Coronary artery occlusion have been filed in association with ASPIRIN (Aspirin). This represents 0.2% of all adverse event reports for ASPIRIN.

190
Reports of Coronary artery occlusion with ASPIRIN
0.2%
of all ASPIRIN reports
16
Deaths
108
Hospitalizations

How Dangerous Is Coronary artery occlusion From ASPIRIN?

Of the 190 reports, 16 (8.4%) resulted in death, 108 (56.8%) required hospitalization, and 11 (5.8%) were considered life-threatening.

Is Coronary artery occlusion Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ASPIRIN. However, 190 reports have been filed with the FAERS database.

What Other Side Effects Does ASPIRIN Cause?

Gastrointestinal haemorrhage (13,172) Anaemia (4,568) Off label use (4,283) Dyspnoea (4,280) Drug hypersensitivity (4,072) Drug ineffective (4,061) Upper gastrointestinal haemorrhage (3,411) Epistaxis (3,214) Rectal haemorrhage (3,057) Acute kidney injury (2,976)

What Other Drugs Cause Coronary artery occlusion?

ADALIMUMAB (1,392) TICAGRELOR (370) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (296) ROSUVASTATIN (283) METOPROLOL (230) SACUBITRIL\VALSARTAN (204) RISANKIZUMAB-RZAA (181) EVOLOCUMAB (162) CLOPIDOGREL BISULFATE (155) ATORVASTATIN (149)

Which ASPIRIN Alternatives Have Lower Coronary artery occlusion Risk?

ASPIRIN vs ASPIRIN DL-LYSINE ASPIRIN vs ASPIRIN LYSINE ASPIRIN vs ASPIRIN\BUTALBITAL\CAFFEINE ASPIRIN vs ASPIRIN\CAFFEINE ASPIRIN vs ASPIRIN\CARISOPRODOL

Related Pages

ASPIRIN Full Profile All Coronary artery occlusion Reports All Drugs Causing Coronary artery occlusion ASPIRIN Demographics